Highline Wealth Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Highline Wealth Partners's NVS Position: Q3 2026 in Review
Highline Wealth Partners increased its Novartis (NVS) stake by 20% in Q3 2026, buying an estimated $7.58K and bringing the position to 303 shares worth $43.2K. The position accounts for 0.01% of the portfolio, ranked #278.
Highline Wealth Partners first reported a position in NVS in Q3 2022 and has held it in 17 quarters since. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Highline Wealth Partners held 303 shares of Novartis worth $43.2K as of Q3 2026.
- Highline Wealth Partners bought 50 Novartis shares in Q3 2026, an estimated $7.58K.
- Novartis made up 0.01% of Highline Wealth Partners's portfolio in Q3 2026, its #278 holding.
- Highline Wealth Partners first reported a position in Novartis in Q3 2022 and has held it in 17 quarters since.
- 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.